uGDB, utilizing next-generation sequencing to detect bladder cancer-associated mutations and DNA alterations, has previously shown associations with recurrence and therapy response.

We recently published a list of 10 AI Stocks That Will Skyrocket. In this article, we are going to take a look at where ...

BioSkryb Genomics and Tecan Group, today introduced a high-throughput single-cell workflow, combining BioSkryb's 384-well ...

Dana Cimilluca is former Wall Street bureau chief at The Wall Street Journal, where he managed a group of reporters and editors covering banks, hedge funds, private-equity firms, M&A and IPOs. He ...

A groundbreaking DNA study reveals how genetic mutations pass through generations, offering new insights into disease and ...

ICMR-NICPR announces DHR sponsored training course on omics technologies: Shardul Nautiyal, Mumbai Saturday, April 26, 2025, 08:00 Hrs [IST] In a significant leap towards advancin ...

We recently published a list of 10 AI Stocks That Will Skyrocket. In this article, we are going to take a look at where ...

Stocks (^DJI, ^GSPC, ^IXIC) are rallying on Wednesday, raising hopes for a more sustainable market rebound. Adam Turnquist, ...

The Philadelphia Eagles look to add to their star-studded roster that helped them win their second Super Bowl in franchise history last season in 2025. Thanks to a late trade, the Eagles swapped ...

MASH is a form of non-alcoholic fatty liver disease (NAFLD) that affects between 6 million to 8 million people in the US alone and for some time has been billed as pharma's next big growth area.